CVRX INC. - COMMON ST
15.37
07-11月-24 12:38:09
15 分の遅延
株式
-0.05
-0.36%
本日の幅
15.04 - 15.79
ISIN
N/A
ソース
NASDAQ
-
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27 12 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
CVRx receives FDA approval for expanded labeling of Barostim
26 12 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
15 11 2023 15:21:43 提供 Nasdaq GlobeNewswire
-
CMS Increases Outpatient Payment for Barostim Procedure
03 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Third Quarter 2023 Financial and Operating Results
26 10 2023 15:15:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference
27 7 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Second Quarter 2023 Financial and Operating Results
25 7 2023 15:15:00 提供 Nasdaq GlobeNewswire
-
11 7 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Set to Join Russell 2000 & 3000 Indexes
22 6 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the William Blair 43rd Annual Growth Stock Conference
25 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports First Quarter 2023 Financial and Operating Results
27 4 2023 15:15:00 提供 Nasdaq GlobeNewswire
-
20 4 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
21 3 2023 10:02:23 提供 Nasdaq GlobeNewswire
-
16 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial
21 2 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
26 1 2023 15:15:00 提供 Nasdaq GlobeNewswire
-
12 1 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 12 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
20 12 2022 15:05:00 提供 Nasdaq GlobeNewswire